Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.69 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.69 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | F7 | P08709 | 4/20 | 0.67 |
| ▸ | F3 | P13726 | 4/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.67 |
| ▸ | PPARG | P37231 | 3/20 | 0.67 |
| ▸ | PPARD | Q03181 | 3/20 | 0.67 |
| ▸ | PPARA | Q07869 | 3/20 | 0.67 |
| ▸ | FABP3 | P05413 | 3/20 | 0.67 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.67 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.67 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.67 |
| ▸ | FABP4 | P15090 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16322672 | 1.00 | ALOX5 (0.69) | ALOX5OXER1EPHX2ALDH1A1F7 | |
| SCHEMBL6851491 | 1.00 | ALOX5 (0.69) | ALOX5OXER1EPHX2ALDH1A1F7 | |
| SCHEMBL6851489 | 1.00 | ALOX5 (0.69) | ALOX5OXER1EPHX2ALDH1A1F7 | |
| SCHEMBL5090838 | 1.00 | ALOX5 (0.69) | ALOX5OXER1EPHX2ALDH1A1F7 | |
| SCHEMBL2187914 | 1.00 | ALOX5 (0.69) | ALOX5OXER1EPHX2ALDH1A1F7 | |
| SCHEMBL814776 | 1.00 | ALOX5 (0.69) | ALOX5OXER1EPHX2ALDH1A1F7 | |
| SCHEMBL13140452 | 1.00 | ALOX5 (0.69) | ALOX5OXER1EPHX2ALDH1A1F7 | |
| SCHEMBL6849890 | 1.00 | ALOX5 (0.69) | ALOX5OXER1EPHX2ALDH1A1F7 | |
| SCHEMBL813264 | 1.00 | ALOX5 (0.69) | ALOX5OXER1EPHX2ALDH1A1F7 | |
| SCHEMBL12479211 | 1.00 | ALOX5 (0.69) | ALOX5OXER1EPHX2ALDH1A1F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2046719-B1 | RING OPENING CROSS-METATHESIS REACTION OF CYCLIC OLEFINS WITH SEED OILS AND THE LIKE | ELEVANCE RENEWABLE SCIENCES (US) | 2013-09-04 | — | — | EP | disclosed |
| US-8501973-B2 | Synthesis of terminal alkenes from internal alkenes via olefin metathesis | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2013-08-06 | — | — | US | disclosed |
| US-8067623-B2 | Producing waxes from soybean oil; ruthenium alkylidene catalytic, simultaneous opening and inserting | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2011-11-29 | — | — | US | disclosed |
| US-7951232-B2 | Surface coating compositions and methods | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2011-05-31 | — | — | US | disclosed |
| US-20100145086-A1 | Synthesis of Terminal Alkenes From Internal Alkenes Via Olefin Metathesis | ELEVANCE RENEWABLE SCIENCES, INC. | 2010-06-10 | — | — | US | disclosed |
| US-20080064891-A1 | Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like | WILMAR TRADING PTE LTD (SG) | 2008-03-13 | — | — | US | disclosed |
| US-20080033026-A1 | Antimicrobial compositions, methods and systems | ELEVANCE RENEWABLE SCIENCES, INC. | 2008-02-07 | — | — | US | disclosed |
| US-20070227400-A1 | Surface coating compositions and methods | WILMAR TRADING PTE LTD (SG) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064891-A1 | Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like | SQLE, COASY, ALOX12 | ALOX5 5/4885OXER1 8/4885EPHX2 166/4885 |
| US-20080033026-A1 | Antimicrobial compositions, methods and systems | DHCR7, SPOUT1, DSTN | ALOX5 50/4885OXER1 905/4885EPHX2 903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.